Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer

Neoplasma

Volumn 54, Issue 5, 2007, Pages 413-423

  Neumanova, R ^a   Petera, J ^b   Frgala, T ^c   Dusek L ^d   Jarkovsky, J ^d   Kuricka, R ^e  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60;

ADULT; AGED; ARTICLE; BREAST AREOLA; BREAST CARCINOMA; BREAST CONSERVING SURGERY; BREAST FIBROSIS; BREAST MALFORMATION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; ESTHETICS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INCISION; INTERSTITIAL RADIATION; LINEAR ACCELERATOR; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RADIATION DOSE; RISK ASSESSMENT; RISK FACTOR; SCAR FORMATION; SURVIVAL RATE; SURVIVAL TIME; TELANGIECTASIA; TREATMENT OUTCOME; TUMOR LOCALIZATION; BRACHYTHERAPY; BREAST TUMOR; CANCER INVASION; CANCER STAGING; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SEGMENTAL MASTECTOMY;

ADULT; BRACHYTHERAPY; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35448934937     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. FISHER B, ANDERSON S, REDMOND C-K, et al.: Reanalysis and results after 12 years of follow up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1462.
2. RUTQUIST LE, ROSE C, CAVALLIN-STAHL E. et al.: A systematic overview of radiation therapy effects in breast cancer. Acta Oncol. 2003, 42(5-6):532-545 Review
3. FISHER B, WICKERHAM DL, DEUTSCH M, et al.: Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 1992,8:153-160.
4. HAMMER J, MAZERON JJ, VAN LIMBERGEN E.: Breast boost - why, how, when? Strahlenther Onkol 1999,175: 478-483.
5. POLGÁR C, FODOR J, MAJOR T, et al.: The Role of boost irradiation in the conservative treatment of stage I -II breast cancer - Review Pathol Oncol Research, 2001,Vol 7, No 4:241-250.
6. STANKUŠOVÁ H, MALINOVÁ B, ROBOVÁ H.: When and how the boost in breast cancer radiotherapy should be applied. Sborník "Onkologie v gynekologii a mammologii" 2004, ISBN 80-86607-09-7:51-53. (In Czech).
7. COLLETTE L, FOURQUET A, HORIOT JC, et al.: Impact of a boost of 16 Gy on local control in patients with early breast cancer: the EORTC 'Boost versus no boost' trial [abstract].Radiother Oncol 2000;56(Suppl 1):46.
8. SOUMAROVÁ R, PERKOVÁ H, ČOUPEK P.: Controversial questions in postoperative radiotherapy of early stages of breast cancer. Klinická onkologie, 2003, 16,1:4-9.
9. FODOR J, MAJOR T, POLGÁR C, et al.: The impact of radiotherapy in the incidence and time of occuerrence of local recurrence in early-stage breast cancer after breast cancer after BCS. Neoplasma 2000,47:181-186. (Pubitemid 30643252)
10. GRAHAM P, FOURQUET A.: Placing the boost in breastconservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy.Clin Oncol. 2006 Apr, 18:210-219
11. POLGÁR C, FODOR J, OROSZ Z. et al.: Elektron and high dose rate brachytherapy boost in the conservative treatment of stage I-II breast cancer, first results of the randomized Budapešt' boost trial. Strahlentherapie und Onkologie 2002, May, 178:615-623
12. CARRIZOSA PMC, OTS SPM, OCANA VC. et al.: Early stage breast cancer conserving treatment: high dose rate brachytherapy boost to the tumor bed. Clin Transl Oncol. 2005 Sep;7(8):344-350
13. VICINI F-A, HORWITZ EM, LACERNA MD, et al.: Longterm outcome with interstitial brachytherapy in the management of patients with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997;37:845-852. (Pubitemid 27181318)
14. HAMMER J, TRACK C, SEEWALD DH. et al.: 192- iridium HDR boost in breast cancer treatment - experience from 644 patients. Radiother Oncol 2000,55(Suppl. 1): 32.
15. BORGER J, KEMPERMANN H, HART A, et al.: Risk factors in breast conservation therapy. J Clin Oncol. 1994; 12: 653-660. (Pubitemid 24110901)
16. KURTZ JM.: Factors which predict breast relapse. Recent Res Cancer Res 1993;127:137-150.
17. VAN LIMBERGEN E.: Indications and technical aspects of brachyterapy in breast conserving treatment of breast cancer. Cancer/Radiothérapie 2003,7:107-120. (Pubitemid 36543091)
18. RABINOVITCH R, FINLAYSON C, PAN Z, et al.: Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study. Int J. Radiat Oncol Biol Phys 2000,47:313-317.
19. DENIAUD-ALEXANDRE E, TOUBOUL E, LEFRANC JP. et al.: Breast conserving surgery and irradiation for early breast cancer: value of surgical clips in the surgical cavity.Cancer Radiother. 2001 Jun, 5:255-261
20. DEUTINGER M, TAYRICH G, RESCH A, BIBER E.: Shape defects after breast conserving therapy of breast cancer - possibilities for primary and secondary corrections. Strahlenther Onkol 1999;175:577-582. (In German).
21. TAYRICH G, RESCH A, BIBER E, et al.: Cosmetic results after breast conserving Therapy and radiation of breast cancer. Acta Chir Austria 1998;30(Suppl 141):43. (In German).
22. RUBIN P, CONSTINE III LS, FAJARDO LF. et al.: EORTC Late Effects Working Group. Overview of late normal tissues (LENT) scoring system. Radiother Oncol 1995;35(1):9-10.
23. BERGER JH, KEMPERMAN H, SMITT HS. et at.: Dose and volume effects on fibrosis after breast conservation therapy.Int J Radiat Oncol Biol Phys. 1994 Dec 1, 30:1073-1081
24. GEORG P, GEORG D, VAN LIMBERGEN E.: The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. Radiother Oncol 2005, Mar, 74:323-330
25. VRIELING C, COLETTE L, FOURQUET A. et al.: The influence of patient and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs.no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000;55:219-232.
26. ICRU - International Commissioning on Radiation Units and Measurements. In: Chassagne D, Dutreix A, editors.: Dose and volume specification for reporting interstitial therapy. ICRU Report, 1997,No. 58.
27. EORTC Breast Cancer Group:Manual for Clinical Research in Breast Cancer. 2th European Breast Cancer Conference Brusel, Sept. 2000, 4th Edition.
28. KAPLAN E.L, MEIER P.: Nonparametric estimation from incomplete observations. Journal of American Statistical Association. 53,1958:457-481.
29. COX D. R.: Regression Models and Life Tables (with Discussion). Journal of the Royal Statistical Society, Series B 34, 1972:187-220.
30. AITCHISON J, SILVEY S. D.: Maximum-likelihood estimation procedures and associated tests of significance. Journal of the Royal Statistical Society, Series B 22, 1960:154-171.
31. FISHER R. A.: Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd 1938.
32. MANN H, WHITNEY D.: On a test of whether one of two variables is stochastically larger than the other. Annals of Mathematical Statistics, 18, 1947:50-60.
33. DIBIASE SJ, KOMARNICKY LT, SCHWARZ GF. et al.: The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.Cancer, 1998, 82:2212-2220.
34. WAZER DE, SCHMIDT-ULLRICH RK, RUTHAZER R. et al.: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.Int J Radiat Oncol Biol Phys 1998, 40:851-858.
35. POLGÁR C.: Radiotherapy of the tumor bed after breast conserving surgery for stag I-II breast cancer: Analysis of efficacy of conventional and novel radiotherapy methods. PhD Theses, 2001,Budapest, (in Hungarian).
36. KRISHNAN L, JEWELL WR, KRISHNAN EC, et al.: Breast cancer with extensive intraductal component: treatment with immediate interstitial boost irradiation.Radiology, 1992,183:273-276.
37. GENNARI R, CINIERI S, COLLEONI M. et al.: The 6th Milan Breast Cancer Conference, Milan, Italy, 16-18 June 2004. Breast Cancer Res. 2004 Oct 10;7:E1.
38. SEDLMAYER F, RAHIM HBK, KOGELNIK H.: Quality assurance in breast cancer brachytherapy: Geographic miss in the interstitial boost treatment of the tumor bed.Int J Radiat Oncol Biol Phys 1996;34:1133-1139.
39. MANNING MA, ARTUR DW, SCHMIDT-ULRICH RK et al.: Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.Int J Radiat Oncol Biol Phys. 2000 Dec, 148:1301-1306
40. ARENAS M, SABATER S, HERNANDEZ V. et al.: Cosmetic outcome of breast conservative treatment for early stage breast cancer. Clin Transl Oncol. 2006 May, 8:334-338